Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marc Léonard is active.

Publication


Featured researches published by Marc Léonard.


Australian Journal of Chemistry | 2010

Chemical modifications on 4-arylpiperazine-ethyl carboxamide derivatives differentially modulate affinity for 5-HT1A, D4.2, and α2A receptors: Synthesis and in vitro radioligand binding studies

Amaury Graulich; Marc Léonard; Mélissa Résimont; Xi-Ping Huang; Bryan L. Roth; Jean-François Liégeois

A series of substituted 4-aryl-piperazine-ethyl heteroarylcarboxamides were prepared and tested in in vitro radioligand binding studies. The presence of a quinoxaline has a favourable impact in terms of serotonin 5-HT1A versus dopamine D4.2 receptor selectivity. Compounds with a 3-CF3 group at the distal phenyl ring are the most effective in terms of affinity and selectivity for 5-HT1A versus D4.2 receptors. A 4-phenyl-1,2,3,6-tetrahydropyridine in place of the corresponding 4-phenyl-piperazine side chain is also favourable not only for the affinity for 5-HT1A and D4.2 receptors but also in some cases for α 2A-adrenoceptors.


Journal of Labelled Compounds and Radiopharmaceuticals | 2016

Gallium-68-labelled NOTA-oligonucleotides: An optimized method for their preparation

Marlies Gijs; Sylvestre Dammicco; Corentin Warnier; An Aerts; Nathalie Impens; Matthias D'Huyvetter; Marc Léonard; Sarah Baatout; André Luxen

One of the most essential aspects to the success of radiopharmaceuticals is an easy and reliable radiolabelling protocol to obtain pure and stable products. In this study, we optimized the bioconjugation and gallium-68 ((68) Ga) radiolabelling conditions for a single-stranded 40-mer DNA oligonucleotide, in order to obtain highly pure and stable radiolabelled oligonucleotides. Quantitative bioconjugation was obtained for a disulfide-functionalized oligonucleotide conjugated to the macrocylic bifunctional chelator MMA-NOTA (maleimido-mono-amide (1,4,7-triazanonane-1,4,7-triyl)triacetic acid). Next, this NOTA-oligonucleotide bioconjugate was radiolabelled at room temperature with purified and pre-concentrated (68) Ga with quantitative levels of radioactive incorporation and high radiochemical and chemical purity. In addition, high chelate stability was observed in physiological-like conditions (37 °C, PBS and serum), in the presence of a transchelator (EDTA) and transferrin. A specific activity of 51.1 MBq/nmol was reached using a 1470-fold molar excess bioconjugate over (68) Ga. This study presents a fast, straightforward and reliable protocol for the preparation of (68) Ga-radiolabelled DNA oligonucleotides under mild reaction conditions and without the use of organic solvents. The methodology herein developed will be applied to the preparation of oligonucleotidic sequences (aptamers) targeting the human epidermal growth factor receptor 2 (HER2) for cancer imaging.


Archive | 2017

Kit for radiolabelling with 68ga comprising a metal inhibitor

Ludovic Wouters; Geoffroy Kaisin; André Luxen; Marc Léonard; Samuel Voccia


Archive | 2017

Mono-, di- or polysaccharide used as metal inhibitor in the preparation of 68ga-chelate-functionalized targeting agent

Ludovic Wouters; Geoffroy Kaisin; André Luxen; Marc Léonard; Samuel Voccia


Tijdschrift voor Nucleaire Geneeskunde | 2015

[18F]UCB-H as a new PET radiotracer for Synaptic vesicle protein 2A: A first clinical trial

Mohamed Ali Bahri; Mathieu Stifkens; Christine Bastin; Joël Aerts; Florian Bretin; Geoffrey Warnock; Tim Buchanan; Christine Mella; Nathalie Mestdagh; Christian Otoul; Franz Koester; Anne Valade; Joël Mercier; Christian Lemaire; Fabrice Giacomelli; Frédéric Mievis; Marc Léonard; Alain Seret; André Luxen; Alain Plenevaux; Eric Salmon


Archive | 2014

[18F]UCB-H AS A BRAIN SV2A RADIOTRACER: A FIRST CLINICAL TRIAL

Mohamed Ali Bahri; Christine Bastin; Joël Aerts; Florian Bretin; Geoffery Warnock; Tim Buchanan; Christine Mella; Nathalie Mestdagh; Christian Otoul; Franz Koester; Anne Valade; Joël Mercier; Christian Lemaire; Frédéric Mievis; Marc Léonard; Alain Seret; André Luxen; Alain Plenevaux; Eric Salmon


Archive | 2014

[18F]UCB-H AS A NEW PET RADIOTRACER FOR SYNAPTIC VESICLE PROTEIN 2A

Mohamed Ali Bahri; Christine Bastin; Joël Aerts; Florian Bretin; Geoffery Warnock; Tim Buchanan; Christine Mella; Nathalie Mestdagh; Christian Otoul; Franz Koester; Anne Valade; Joël Mercier; Christian Lemaire; Fabrice Giacomelli; Frédéric Mievis; Marc Léonard; Alain Seret; André Luxen; Alain Plenevaux; Eric Salmon


Archive | 2013

Fully Automated Production of 68Ga-DOTA-NOC with a Trasis miniAIO® Synthesizer

Marc Léonard; Joël Aerts; Samuel Voccia; Christian Lemaire; Jean-Luc Morelle; Gauthier Phillipart; André Luxen


Archive | 2013

Quality controls of no-carrier-added aromatic amino acids such as FDOPA and FTYR produced at curie level

Lionel Libert; Christian Lemaire; Fabrice Giacomelli; Marc Léonard; Alain Plenevaux; Xavier Franci; André Luxen


Archive | 2013

Customizing an adaptive case management software in a GMP production lab as a quality management system for clinical trial PET radiopharmaceuticals development and production

Joël Aerts; Renard; Marc Léonard; André Luxen

Collaboration


Dive into the Marc Léonard's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge